Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2017

Open Access 01-12-2017 | Research article

Declining rates of sterilisation reversal procedures in western Australian women from 1990 to 2008: the relationship with age, hospital type and government policy changes

Authors: Khadra A. Jama-Alol, Alexandra P. Bremner, Gavin Pereira, Louise M. Stewart, Eva Malacova, Rachael Moorin, David B. Preen

Published in: BMC Women's Health | Issue 1/2017

Login to get access

Abstract

Background

Female sterilisation is usually performed on an elective basis at perceived family completion, however, around 1–3% of women who have undergone sterilisation elect to undergo sterilisation reversal (SR) at a later stage. The trends in SR rates in Western Australia (WA), proportions of SR procedures between hospital types (public and private), and the effects of Federal Government policies on these trends are unknown.

Methods

Using records from statutory state-wide data collections of hospital separations and births, we conducted a retrospective descriptive study of all women aged 15–49 years who underwent a SR procedure during the period 1st January 1990 to 31st December 2008 (n = 1868 procedures).

Results

From 1991 to 2007 the annual incidence rate of SR procedures per 10,000 women declined from 47.0 to 3.6. Logistic regression modelling showed that from 1997 to 2001 the odds of women undergoing SR in a private hospital as opposed to all other hospitals were 1.39 times higher (95% CI 1.07–1.81) and 7.51 times higher (95% CI 5.46–10.31) from 2002 to 2008. There were significant decreases in SR rates overall and among different age groups after the Federal Government interventions.

Conclusion

Rates of SR procedures in WA have declined from 1990 to 2008, particularly following policy changes such as the introduction of private health insurance (PHI) policies. This suggests decisions to undergo SR may be influenced by Federal Government interventions.
Literature
1.
Melville C, Bigrigg A. Male and female sterilization. Obstet, Gynaecol Reprod Med. 2008;18(12):330–4.CrossRef
2.
Chan LM, Westhoff CL. Tubal sterilization trends in the United States. Fertil Steril. 2010;94(1):1–6.CrossRefPubMed
3.
Jama-Alol KA, Bremner AP, Stewart LM, Kemp-Casey A, Malacova E, Moorin R, Shirangi A, Preen DB. Declining rates of sterilization procedures in western Australian women from 1990 to 2008: the relationship with age, hospital type, and government policy changes. Fertil Steril. 2016;106(3):704–9.CrossRefPubMed
4.
Petrucco OM, Silber SJ, Chamberlain SL, Warnes GM, Davies M. Live birth following day surgery reversal of female sterilisation in women older than 40 years: a realistic option in Australia? Med J Aust. 2007;187(5):271–2.PubMed
5.
Yossry M, Aboulghar M, D’Angelo A, Gillett W. In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation. Cochrane Database Sys Rev. 2006;3:CD004144. doi:10.​1002/​14651858.​CD004144.​pub2.
6.
Van Voorhis B. Comparison of tubal ligation reversal procedures. Clin Obstet Gynecol. 2000;43(3):641–9.CrossRefPubMed
7.
Platz-Christensen JJ, Tronstad SE, Johansson O, Carlsson SA. Evaluation of regret after tubal sterilization. Int J Gynecol Obstet. 1992;38:223–6.
8.
Petrucco OM, Silber SJ, Chamberlain SL, Warnes GM, Davies M. Live birth following day surgery reversal of female sterilisation in women older than 40 years: a realistic option in Australia? MJA. 2007;187(5):271–3.PubMed
9.
Wilcox L, Chu S, Peterson H. Characteristics of women who considered or obtained tubal reanastmosis: results from a prospective study of tubal sterilization. Obstet Gynecol. 1990;75:661–5.PubMed
10.
Hillis SD, Marchbanks PA, Tylor LR, Peterson HB. Poststerilization regret: findings from the United States collaborative review of sterilization. Obstet Gynecol. 1999;93(6):889–95.PubMed
11.
Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception. 2006;73(2):205–10.CrossRefPubMed
12.
Chambers GM, Wang YA, Chapman MG, Hoang VP, Sullivan EA, Abdalla HI, Ledger W. What can we learn from a decade of promoting safe embryo transfer practices? A comparative analysis of policies and outcomes in the UK and Australia, 2001-2010. Hum Reprod. 2013;28(6):1679–86.CrossRefPubMed
13.
Hopkins S, Kidd MP. The determinants of the demand for private health insurance under Medicare. Appl Econ. 1996;28(12):1623–32.CrossRef
14.
Podger A. Reforming the Australian health care system: a government perspective. Health Aff (Millwood). 1999;18(3):111.
15.
Seah DSE, Cheong TZ, Anstey MHR. The hidden cost of private health insurance in Australia. Aust Health Rev. 2013;37(1):1–3.
16.
Robson A, Francesco P. Private health insurance incentives in Australia: the effects of recent changes to price carrots and income sticks. Geneva Pap R I-Iss P. 2012;37(4):725–44.CrossRef
17.
Butler JRG. Adverse selection, genetic testing and life insurance-lessons from health insurance in Australia. Agenda. 2003;10(1):73–89.
18.
Lopata A, Johnston IWH, Hoult IJ, Speirs AI. Pregnancy following intrauterine implantation of an embryo obtained by in vitro fertilization of a preovulatory egg. Fertil Steril. 1980;33(2):117–20.CrossRefPubMed
19.
Saunders C. Medicare's expensive cut. Aust Doct. 2006;1:1.
20.
Guest R. The baby bonus: a dubious policy initiative. Policy (St Leonards). 2007;23(1):11.
21.
Drago R, Sawyer K, Shreffler K, Warren D, Wooden M. Did Australia’s baby bonus increase fertility intentions and births? Popul Res Policy Rev. 2011;30(3):381–97.CrossRef
22.
Mosher W, Martinez G, Chandra A, Abma J, Willson S. Use of contraception and use of family planning services in the United States: 1982–2002. Advance data from vital and health statistics. Hyattsville: National Center for Health Statistics; 2004. p. 350.
23.
Rickards L, Fox K, Roberts C, Fletcher LEG. Results from the 2002 general household survey. In: Living in Britain, vol. 31. London: The Stationery Office; 2004. p. 175–80.
24.
World Health Organization (WHO). Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva: WHO; 1977.
25.
MacKay AP, Kieke BA, Koonin LMJ, Beattie K. Tubal sterilization in the United States, 1994-1996. Fam Plan Perspect. 2001;33(4):161–5.CrossRef
26.
National Centre for Classification in Health: Gynaecological procedures, ICD-10-AM. In., 6th Edn edn. Lidcombe: National Centre for Classification in Health; 2008.
27.
Holman CDAJ, Bass AJ, Rouse IL, MST H. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23(5):453–9.CrossRefPubMed
28.
SPSS. PASW statistics for windows, version 18.0. Chicago: SPSS Inc.; 2009.
29.
Trussell J, Guilbert É, Hedley A. Sterilization failure, sterilization reversal, and pregnancy after sterilization reversal in Quebec. Obstet Gynecol. 2003;101(4):677–84.PubMed
30.
American Society of Reproductive Medicine (ASRM). Committee opinion: role of tubal surgery in the era of assisted reproductive technology. Fertil Steril. 2012;97:539–45.CrossRef
31.
Hirshfeld-Cytron J, Winter J. Laparoscopic tubal reanastomosis versus in vitro fertilization: cost-based decision analysis. Am J Obstet Gynecol. 2013;209(1):56.e51–6.CrossRef
32.
Messinger LB, Alford CE, Csokmay JM, Henne MB, Mumford SL, Segars JH, Armstrong AY. Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation. Fertil Steril. 2015;104(1):32–38.e34.CrossRefPubMedPubMedCentral
33.
Malacova E, Kemp A, Hart R, Jama-Alol K, Preen DB. Effectiveness of in vitro fertilization in women with previous tubal sterilization. Contraception. 2015;91(3):240–4.CrossRefPubMed
34.
Chambers GM, Ho MT, Sullivan EA. Assisted reproductive technology treatment costs of a live birth: an age-stratified cost-outcome study of treatment in Australia. Med J Aust. 2006;184(4):155–8.PubMed
Metadata
Title
Declining rates of sterilisation reversal procedures in western Australian women from 1990 to 2008: the relationship with age, hospital type and government policy changes
Authors
Khadra A. Jama-Alol
Alexandra P. Bremner
Gavin Pereira
Louise M. Stewart
Eva Malacova
Rachael Moorin
David B. Preen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2017
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-017-0470-3

Other articles of this Issue 1/2017

BMC Women's Health 1/2017 Go to the issue

Research article

Awareness, attitudes and perceptions regarding HIV and PMTCT amongst pregnant women in Guinea-Bissau– a qualitative study

Correction

Correction to: The Cedar Project: Using Indigenous-specific determinants of health to predict substance use among young pregnant-involved Indigenous women in Canada

Research article

Can community health workers play a greater role in increasing access to medical abortion services? A qualitative study

Research article

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status

Research article

Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study

Research article

Effect of structured training programme on the knowledge and behaviors of breast and cervical cancer screening among the female teachers in Turkey